CRISPR Therapeutics AG (NASDAQ:CRSP)

88.73
BATS BZX Real-Time Price
As of 12:50pm ET
 -3.38 / -3.67%
Today’s Change
32.30
Today|||52-Week Range
111.90
+45.69%
Year-to-Date

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 105.00, with a high estimate of 140.00 and a low estimate of 47.00. The median estimate represents a +18.34% increase from the last price of 88.73.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.17
Sales
$2.1M
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.68%
 
 
 
 
 
 
Growthannually -507.04%
 
 
 
 
 
 

Sales

Growthquarterly 4,583.44%
 
 
 
 
 
 
Growthannually -97.86%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.